Substance use to enhance academic performance among Australian university students

Australian Government, 2013 Australian Institute of Health and Welfare, 2011 Babcock, 2000, Student perceptions of methylphenidate abuse at a public liberal arts college, Journal of American College Health, 49, 143, 10.1080/07448480009596296 Barnes, 2012, Borrowing from sleep to pay work and family: Expanding time-based conflict to the broader nonwork domain, Personnel Psychology, 65, 789, 10.1111/peps.12002 Cakic, 2009, Smart drugs for cognitive enhancement: Ethical and pragmatic considerations in the era of cosmetic neurology, Journal of Medical Ethics, 35, 611, 10.1136/jme.2009.030882 Castaldi, 2012, Use of cognitive enhancement medication among Northern Italian university students, Journal of Addiction Medicine, 6, 112, 10.1097/ADM.0b013e3182479584 Cross, 2013, Innovative techniques for estimating illegal activities in a human–wildlife-management conflict, PLoS ONE, 8, e53681, 10.1371/journal.pone.0053681 Curcio, 2006, Sleep loss, learning capacity and academic performance, Sleep Medicine Reviews, 10, 323, 10.1016/j.smrv.2005.11.001 DeSantis, 2008, Illicit use of prescription ADHD medications on a college campus: A multimethodological approach, Journal of American College Health, 57, 315, 10.3200/JACH.57.3.315-324 Dietz, 2013, Randomized response estimates for the 12-month prevalence of cognitive-enhancing drug use in university students, Pharmacotherapy, 33, 44, 10.1002/phar.1166 Ebejer, 2012, Attention deficit hyperactivity disorder in Australian adults: Prevalence, persistence, conduct problems and disadvantage, PLoS ONE, 7, e47404, 10.1371/journal.pone.0047404 Elsabagh, 2005, Differential cognitive effects of Ginkgo biloba after acute and chronic treatment in healthy young volunteers, Psychopharmacology, 179, 437, 10.1007/s00213-005-2206-6 Forlini, 2009, Disagreements with implications: Diverging discourses on the ethics of non-medical use of methylphenidate for performance enhancement, BMC Medical Ethics, 10, 9, 10.1186/1472-6939-10-9 Franke, 2011, Non-medical use of prescription stimulants and illicit use of stimulants for cognitive enhancement in pupils and students in Germany, Pharmacopsychiatry, 44, 60, 10.1055/s-0030-1268417 Galesic, 2009, Effects of questionnaire length on participation and indicator of response quality in a web survey, Public Opinion Quarterly, 73, 349, 10.1093/poq/nfp031 Graham, 2011, Mapping the moral domain, Journal of Personality and Social Psychology, 101, 366, 10.1037/a0021847 Greely, 2008, Towards responsible use of cognition enhancing drugs by the healthy, Nature, 456, 702, 10.1038/456702a Gucciardi, 2011, An examination of the sport drug control model with elite Australian athletes, Journal of Science and Medicine in Sport, 14, 469, 10.1016/j.jsams.2011.03.009 Hall, 2005, Illicit use of prescribed stimulant medication among college students, Journal of American College Health, 53, 167, 10.3200/JACH.53.4.167-174 Housden, 2011, Cognitive enhancing drugs: Neuroscience and society, 113 Judson, 2009, Illicit use of prescription stimulants among college students: Prescription status, theory of planned behaviour, knowledge and self-diagnostic tendencies, Psychology, Health & Medicine, 14, 97, 10.1080/13548500802126723 Kalmijn, 1997, Polyunsaturated fatty acids, antioxidants and cognitive function in very old men, American Journal of Epidemiology, 145, 33, 10.1093/oxfordjournals.aje.a009029 Kennedy, 2009, Cognitive and mood effects of 8 weeks’ supplementation with 400mg or 1000mg of the omega-3 essential fatty acid docosahexaenoic acid (DHA) in healthy children aged 10–12 years, Nutritional Neuroscience, 12, 48, 10.1179/147683009X388887 Kimergård, 2011, Policy recommendations to deal with academic doping in Denmark-a successful transfer of a doping control framework?, INHDR Kirby, 2011, A qualitative analysis of the experience of elite athletes who have admitted to doping for performance enhancement, International Journal of Sport Policy and Politics, 3, 205, 10.1080/19406940.2011.577081 Lanni, 2008, Cognitive enhancers between treating and doping the mind, Pharmacological Research, 57, 196, 10.1016/j.phrs.2008.02.004 Lee, 1997, Determination of the best significance level in forward stepwise logistic regression, Communication in Statistics-Simulation and Computation, 26, 559, 10.1080/03610919708813397 Low, 2002, Illicit use of psychostimulants among college students: A preliminary study, Psychology, Health and Medicine, 7, 283, 10.1080/13548500220139386 Lucke, 2012, Is the non-medical use of prescription stimulants a problem in Australia?, Medical Journal of Australia, 197, 145, 10.5694/mja11.10578 Mazanov, 2002, A comparison of predictors of the adolescent intention to smoke with adolescent current smoking using discriminant function analysis, British Journal of Health Psychology, 7, 185, 10.1348/135910702169439 McCabe, 2005, Non-medical use of prescription stimulants among US college students: Prevalence and correlates from a national survey, Addiction, 99, 96, 10.1111/j.1360-0443.2005.00944.x McCabe, 2007, Drug use related problems among non-medical users of prescription stimulants: A web-based survey of college students from a Midwestern university, Drug and Alcohol Dependence, 91, 69, 10.1016/j.drugalcdep.2007.05.010 McInnis, 2002 Partridge, 2012, A comparison of attitudes towards cognitive enhancement and legalized doping in sport in a community sample of Australian adults, AJOB Primary Research, 3, 81, 10.1080/21507716.2012.720639 Partridge, 2013, Australian university students’ attitudes towards the use of prescription stimulants as cognitive enhancers: Perceived patterns of use, efficacy and safety, Drug and Alcohol Review, 32, 295, 10.1111/dar.12005 Partridge, 2011, Smart drugs as common as coffee: Media hype about neuroenhancement, PLoS ONE, 6, e28416, 10.1371/journal.pone.0028416 Petróczi, 2008, Comfort in big numbers: Does over-estimation of doping prevalence in others indicate self-involvement?, Journal of Occupational Medicine and Toxicology, 3, 19, 10.1186/1745-6673-3-19 Rabiner, 2009, Motives and perceived consequences of non-medical ADHD use by college students: Are students treating themselves for attention problems?, Journal of Attention Disorders, 13, 259, 10.1177/1087054708320399 Reissig, 2009, Caffeinated energy drinks – A growing problem, Drugs and Alcohol Dependence, 99, 1, 10.1016/j.drugalcdep.2008.08.001 Repantis, 2010, Modafinil and methylphenidate for neuroenhancement in healthy individuals: A systemic review, Pharmacological Research, 62, 187, 10.1016/j.phrs.2010.04.002 Sandberg, 2011, Cognition enhancement: Upgrading the brain, 71 Sandberg, 2011, The social and economic impacts of cognitive enhancement, 92 Schermer, 2008, On the argument that enhancement is cheating, Journal of Medical Ethics, 34, 85, 10.1136/jme.2006.019646 Schermer, 2009, The future of psychopharmacological enhancements: Expectations and policies, Neuroethics, 2, 75, 10.1007/s12152-009-9032-1 Smith, 2011, Are prescription stimulants smart pills? The epidemiology and cognitive neuroscience of prescription stimulant use by normal healthy individuals, Psychological Bulletin, 137, 717, 10.1037/a0023825 Snitz, 2009, Ginkgo biloba for preventing cognitive decline in older adults, Journal of American Medical Association, 302, 2663, 10.1001/jama.2009.1913 Spector, 1988, Development of the work locus of control scale, Journal of Occupational Psychology, 61, 335, 10.1111/j.2044-8325.1988.tb00470.x Spector, 2006 Teter, 2010, Non-medical use of prescription stimulants and depressed mood among college students: Frequency and routes of administration, Journal of Substance Abuse Treatment, 38, 292, 10.1016/j.jsat.2010.01.005 Teter, 2006, Illicit drug use of specific prescription stimulants among college students: Prevalence, motives and routes of administration, Pharmacotherapy, 26, 1501, 10.1592/phco.26.10.1501 White, 2006, Stimulant medication use, misuse and abuse in an undergraduate and graduate student sample, Journal of American College Health, 54, 261, 10.3200/JACH.54.5.261-268 Wilens, 2007, Misuse and diversion of stimulants prescribed for ADHD: A systematic review of the literature, Journal of the American Academy of Child and Adolescent Psychiatry, 47, 21, 10.1097/chi.0b013e31815a56f1